Echocardiographic recognition of a criss-cross heart with double outlet right ventricle.

Crisscross heart (CCH) is a rare cardiac malformation characterized by crossing of the inflow streams of the two ventricles due to an apparent twisting of the heart about its long axis. The developmental mechanisms and causes of CCH are remaining unknown. Neonates mainly presents with cyanosis and a systolic murmur. We herein present a case of CCH with concordant atrioventriculo connections with double outlet right ventricle (DORV) which was diagnosed by echocardiography.

Accuracy of pulse oximetry screening for detecting critical congenital heart disease in the newborns in rural hospital of Central India.

BACKGROUND: Congenital cardiovascular malformations are the most common category of birth defects and responsible for mortality in the first twelve months of life. Critical congenital heart disease (CCHD) will be present in approximately one quarter of these children, which requires catheter or surgery intervention in the first year of life. AIM: To determine the accuracy of pulse oximetry for detecting clinically unrecognized CCHD in the newborns. METHODS: Pulse oximetry was performed on clinically normal newborns within first 4 hours of life. If screening oxygen saturation (SpO2) was below 90%, echocardiography was then performed. INCLUSION CRITERIA: All newborns who were admitted in postnatal ward & NICU. EXCLUSION CRITERIA: Out born babies and babies with a prenatal diagnosis of duct dependent circulation. RESULTS: Pulse-oximetric screening was performed on 2110 clinically normal newborns. Low SpO2 (<90%) was found in eight babies seven of them had CCHD, including three neonates with TGA, two with tricuspid atresia, one with tetralogy of fallot and one with transposition of great vessels. A pulse oximetry cut-off value of below 90% for detecting CCHD showed 100% sensitivity, 99.95% specificity, 87.50% positive predictive value, 100% negative predictive value. CONCLUSIONS: Pulse oximetry is safe, feasible and noninvasive, can be used as screening tool for detecting CCHD in clinically normal newborn. If SpO2 is below 90% in clinically normal newborns within 4 hours of birth, urgent echocardiography is suggested to rule out CCHD.